A detailed history of Janney Montgomery Scott LLC transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 13,310 shares of TAK stock, worth $177,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,310
Previous 15,311 13.07%
Holding current value
$177,422
Previous $198,000 4.55%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$13.0 - $15.08 $26,013 - $30,175
-2,001 Reduced 13.07%
13,310 $189,000
Q2 2024

Jul 25, 2024

SELL
$12.6 - $13.67 $54,986 - $59,655
-4,364 Reduced 22.18%
15,311 $198,000
Q1 2024

May 01, 2024

SELL
$13.89 - $15.04 $102,577 - $111,070
-7,385 Reduced 27.29%
19,675 $273,000
Q4 2023

Feb 07, 2024

SELL
$13.36 - $15.43 $117,527 - $135,737
-8,797 Reduced 24.53%
27,060 $386,000
Q3 2023

Nov 08, 2023

SELL
$15.03 - $16.32 $304,026 - $330,120
-20,228 Reduced 36.07%
35,857 $555,000
Q2 2023

Jul 26, 2023

SELL
$15.57 - $17.11 $223,086 - $245,152
-14,328 Reduced 20.35%
56,085 $881,000
Q1 2023

Apr 28, 2023

SELL
$15.28 - $16.48 $35,434 - $38,217
-2,319 Reduced 3.19%
70,413 $1.16 Million
Q4 2022

Feb 01, 2023

SELL
$12.42 - $15.62 $469,885 - $590,951
-37,833 Reduced 34.22%
72,732 $1.14 Million
Q3 2022

Oct 25, 2022

SELL
$12.8 - $28.65 $24,806 - $55,523
-1,938 Reduced 1.72%
110,565 $1.43 Million
Q2 2022

Aug 03, 2022

BUY
$13.12 - $15.03 $1.03 Million - $1.18 Million
78,779 Added 233.6%
112,503 $1.56 Million
Q1 2022

May 04, 2022

BUY
$13.54 - $15.35 $456,622 - $517,663
33,724 New
33,724 $483,000
Q4 2021

Jan 27, 2022

SELL
$13.17 - $16.4 $158,645 - $197,554
-12,046 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$16.3 - $17.26 $196,349 - $207,913
12,046 New
12,046 $197,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.